Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Helix

Explore full profile

The leading population genomics company working at the intersection of clinical care, research, and genomics

San Mateo, United StatesFounded 2015Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2021
Headcount 500–1k Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Helix and the history behind them.

About Helix

Helix.com is a pioneering startup that operates in the healthcare and life sciences sector, with a focus on genomics. The company's mission is to integrate genomics into the fabric of healthcare, thereby transforming health organizations and fueling their future growth. Helix serves a diverse range of clients, including health systems, public health entities, and life science companies.

Read full description

The company's business model revolves around making genomics accessible and actionable. They provide solutions that enable their clients to deliver personalized and effective healthcare at scale. This not only improves patient outcomes but also reduces costs, thereby creating strategic value for their clients.

Helix also plays a crucial role in the field of medical research, diagnosis, treatment, and prevention. By leveraging the power of genomics, they provide actionable insights that accelerate research and development, reduce costs, and improve outcomes. This helps their clients stay at the forefront of innovation and bring life-changing therapies to market faster.

In addition, Helix operates one of the nation's most expansive clinical Next-Generation Sequencing (NGS) labs. NGS is a high-throughput DNA sequencing technology that enables faster and more efficient genetic analysis. Through their extensive collaborations with healthcare organizations, Helix equips public health entities with cutting-edge genomic technologies and resources. This allows them to push the boundaries of their research, monitor diseases more effectively, and respond to outbreaks more efficiently.

In summary, Helix.com is a dynamic startup that is revolutionizing the healthcare and life sciences sector by making genomics accessible and actionable.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
San Mateo, United States
Employees
599
Open positions
4
Dealroom signal
83.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Testing, Biotechnology, DNA, Genetics and genomics, Genome Engineering, Direct-to-Consumer, Tech for Patients, Rumoured $1B
Technology
Big Data
Business model
Manufacturing
Client focus
b2b, b2c
Investment activity
1 company, latest Aug 2022
Capital deployed
—
Preferred round
SERIES A

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jun 2021 $50M $1B Temasek · Mayo Clinic · DFJ Growth · Warburg Pincus —
GRANTOther financing Jul 2020 $33M — National Institutes of Health —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Helix website traffic

Latest recorded traffic for Helix is 240K monthly website visits, up 41.2% over the last three months. Helix's team grew 7% over the past year.

Latest monthly visits240K 3-month web change+41.2% 1-year team growth+7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • National Institutes of Health

Series A13 investors entered at this stage

Team profiled 40 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
12 countries with
team presence
🇺🇸 United States85.2%
🇲🇽 Mexico5.7%
🇨🇦 Canada2.4%
🇭🇺 Hungary1.9%
🇸🇪 Sweden0.9%
Top 5 of 12 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Helix on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Helix’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.